Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      The next person to shop your store may not be a person at all

      AI shopping agents are rewriting the rules of online retail across North America

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Cohere's Aidan Gomez bets the house on 'sovereign AI' with Aleph Alpha merger valuing the group at $20bn

      Cohere CEO Aidan Gomez on stage discussing the Toronto AI lab's strategy

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Moonvalley's Naeem Talukdar is selling Hollywood the one thing rival AI video tools cannot: legal cover

      Moonvalley's Marey AI video model produces Hollywood-grade footage trained on licensed data

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
Tuesday 16 September 2025 5:35 am  |  Updated:  Monday 15 September 2025 1:43 pm

Big pharma’s devastating retreat from the UK

By: Oliver Dean

Add as a preferred source on Google
Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
Astrazeneca had previously axed a £200m expansion over the UK's drug pricing

Merck and AstraZeneca’s withdrawal from UK investment is a warning signal to Rachel Reeves – but is she listening? Asks Oliver Dean

Both AstraZeneca and Merck’s decision to abandon their respective UK expansions is more than a corporate setback. It is a catastrophic loss of jobs, investment and future innovation and the public are now poorer as a result. Time and again, the government has boasted that it is pro-growth and pro-business, but unless it changes course on its economic strategy, more and more firms will abandon Britain, and more and more people will be worse off.

As many have pointed out, Merck’s decision did not come out of the blue. For years, the life sciences sector has warned that Britain undervalues medicines and punishes success. Sir John Bell, a leading British scientist, hit the nail on the head when he argued that Britain has, “great science in academia” and “great biotech companies,” but without large businesses properly committing, “it isn’t going to work.” Big Pharma’s retreat is proof that the warnings were not idle.

But perhaps the most pertinent point to make is that this retreat is not restricted to the pharmaceutical sector. Business confidence in the government is on the decline and has been for well over a year. Since the government came into office, firms have been sounding the alarm but the Chancellor has repeatedly ignored them. The Institute of Directors’ Economic Confidence Index sat at -72 in July, down from -53 in June, signalling businesses remain overwhelmingly pessimistic about the direction of the British economy.

Plunging business confidence

The British Chambers of Commerce now expects business investment to grow by just 1.6 per cent in 2025, far weaker than earlier forecasts of 4.8 per cent. Coupled with unemployment being tipped to climb to 4.6 per cent by the end of the year, it is evident that business confidence is dropping. 

To make matters worse, in July 2025 the UK economy flatlined with growth stagnating. Alongside this, more than 125 businesses have signed an open letter in partnership with the Jobs Foundation, urging the government to deliver tax relief to help get young people into work. Their plea has so far been met with silence.

This silence is telling, however. It paints the picture that the government views businesses and the investment they bring as secondary. 

Businesses are telling the government loud and clear that Britain is becoming a harder place to invest in, to hire people and to grow. Yet the response from Labour has been more tax and more uncertainty

Businesses are telling the government loud and clear that Britain is becoming a harder place to invest in, to hire people and to grow. Yet the response from Labour has been more tax and more uncertainty.

If firms believe Britain offers low returns and high risk, they will go elsewhere and they will take their jobs, investment and research with them. That leaves ordinary Britons paying the price through weaker growth, stagnating wages and overstretched public services.

The government must face up to reality. A growing economy goes hand in hand with businesses that feel welcome. That means reversing punishing tax hikes that discourage investment. It means providing regulatory stability, particularly in high-value sectors like life sciences, technology and advanced manufacturing. It means rewarding innovation with credible tax incentives rather than suffocating rebate schemes. And it means publishing a serious growth plan in the upcoming Budget that shows that Britain is once again open for business. As the Shadow Chancellor Mel Stride put it recently, we need “responsible radicalism” when it comes to our economy, and we need it now.

Labour insists it is the party of growth. The Chancellor bragged that this would be the most pro-business economy in modern British history. But soundbites are not what delivers growth. It requires a government that sees business not as a magic money tree, but as a partner it can work with. Merck’s retreat has signalled that the Chancellor needs to get her act together, and her budget is the perfect opportunity to prove that she has.

Oliver Dean is a political commentator with Young Voices UK. He studies History and Politics at the London School of Economics and Political Science (LSE) where he is the President of the LSE Hayek Society.

Read more

Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Opinion

Categories

  • Opinion

People & Organisations

  • Astrazeneca
  • Labour Party
  • Merck
  • Rachel Reeves
  • UK economy

Trending Articles

  • KPMG’s Summer Friday half-day rollback signals deeper woes for Big Four giants

  • Inflation expectations at record high in interest rates signal

  • London Tech Week sums up everything wrong with UK tech

  • KPMG report on AI found riddled with AI hallucinations

  • UK economy falters as deeper damage to growth to come

More from CityAM

  • Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors

    Business Wire
  • ZayZoon, the Calgary fintech born on a fishing boat, posts 1,487% growth as earned wage access goes mainstream

    ZayZoon co-founder Tate Hackert built the Calgary fintech around earned wage access
  • Realignment with the EU is a £15bn betrayal

    Opinion
    UK-EU border alignment discussion, highlighting £15bn GDP impact and trade concerns, with a focus on economic implications
  • Botpress raises $25m as Quebec's Sylvain Perron pitches his startup as the 'infrastructure layer' for AI agents

    Botpress product UI: the Quebec startup pitches itself as the infrastructure layer for enterprise AI agents
  • King’s Speech: Under Labour, Britain looks like a bad bet

    Opinion
    King delivering an impactful speech at a formal event, addressing a captivated audience, symbolizing leadership and author...
  • FluidAI wins US FDA clearance for its surgical monitor as Waterloo's Youssef Helwa targets 100,000 operations

    FluidAI's Origin surgical monitor wins FDA clearance for use in US hospitals
  • Starmer’s Europe reset risks strangling UK AI sector with EU regulation

    Tech
    Keir Starmer
  • Labour selects Burnham and Reform UK picks plumber for by-election battle

    Economics
    Andy Burnham speaking at a Labour Party event, addressing current political issues, with a focused and determined expression.
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
Copyright 2026 CityAM Limited